Table 1.
Baseline characteristics.
| Characteristics | Value, n (%) | |
| Age (years) |
|
|
|
|
40-49 | 2 (17) |
|
|
60-69 | 6 (50) |
|
|
70-79 | 4 (33) |
| Hematological disorder |
|
|
|
|
Multiple myeloma | 4 (33) |
|
|
Myelodysplastic syndrome | 2 (17) |
|
|
β-Thalassemia | 1 (8) |
|
|
Non-Hodgkin lymphoma | 5 (42) |
| Treatment |
|
|
|
|
Red blood cell transfusion | 4 (33) |
|
|
R-CHOPa | 4 (33) |
|
|
Carfilzomib and Dexamethason | 3 (25) |
|
|
Carfilzomib, Lenalidomide and Dexamethasone | 1 (8) |
| Skin color |
|
|
|
|
White | 11 (92) |
|
|
Dark | 1 (8) |
| Sex |
|
|
|
|
Male | 10 (83) |
|
|
Female | 2 (17) |
aR-CHOP: doxorubicin, cyclophosphamide, vincristine, rituximab, and prednisone.